News

Breakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. WILMINGTON, Mass., May 4, 2021 /PRNewswire/ — Micro Medical Solutions (MMS), an emerging leader in the treatment of CLTI, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its MicroStent vascular stent. […]

Read More

The 2.5 mm stent will make it possible for more patients with CLI to be treated, reducing the rate of amputation. WILMINGTON, Mass., October 13, 2020 — Micro Medical Solutions (MMS) today announced CE Mark approval for the 2.5 mm MicroStent vascular stent, the smallest diameter MicroStent to date. The MicroStent is part of the […]

Read More

Major milestone reached in journey toward FDA approval for potentially limb-saving treatment of peripheral artery disease WILMINGTON, Mass., May 12 , 2020 — Micro Medical Solutions (MMS) today announced the first implantation of the MicroStent vascular stent in the FDA randomized, multicenter pivotal clinical study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt […]

Read More

Clinical investigators will study the safety and efficacy of this microvascular device designed to restore blood flow and reduce amputations resulting from below the knee peripheral artery disease WILMINGTON, Mass., June 24, 2019 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced […]

Read More

The company establishes networks to deliver this critical technology following recent approvals in the EU and Latin America. WILMINGTON, Mass., March 12, 2019 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has established distribution agreements for MicroStent in […]

Read More

As MMS prepares for approval of their pivotal clinical trial of the company’s flagship MicroStent device, one of healthcare’s top growth experts will help shape the company’s future WILMINGTON, Mass., May 14, 2019 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced […]

Read More

With a longer, more robust access system and new stent sizes, physicians have more options to access and open arteries affected by critical limb ischemia and prevent lower-leg amputations. WILMINGTON, Massachusetts, November 5, 2018 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions designed to improve clinical outcomes and quality of […]

Read More

A clinical trial is underway for the MicroStent microvascular device, which is designed to open occluded arteries and prevent below-the-knee amputations.

Read More

To accelerate study of the MicroStent microvascular device and other new technologies designed to prevent amputation, MMS has assembled six world leaders in treating peripheral artery disease and critical limb ischemia.

Read More

Back To Top